EUCTR2005-001258-26-IT进行中（未招募）不适用
An 8 week extension to a randomized, double-blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus anamlodipine treatment strategy in achieving blood pressure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapy - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,244
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-MSSPB 8805;140 mmHg, and/or MSDBP 8805;90 mmHg and currently treated with either valsartan 320 mg/HCTZ 25 mg or amlodipine 10 mg/HCTZ 25 mg at visit C -written informed consent to partecipate in the extension study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Premature discontinuation in the core study or failure to comply with the core study protocol -Any patient that the investigator decides should not participate in the extension
研究者
相似试验
进行中（未招募）
1 期
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEUCTR2005-001258-26-GBovartis Pharma Services AG
进行中（未招募）
不适用
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood pressure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEUCTR2005-001258-26-DEovartis Pharma Services AG224
进行中（未招募）
1 期
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment strategy in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEssential hypertensionEUCTR2005-001258-26-IEovartis Pharma Services AG
进行中（未招募）
不适用
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEUCTR2005-001258-26-DKovartis Pharma Services AG224
进行中（未招募）
不适用
An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment strategy in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapyEUCTR2005-001258-26-FIovartis Pharma Services AG224